ScreenerHero

NTRBW Nutriband Inc. - Warrant

NAS · US · Healthcare · Biotechnology · nutriband.com
1.310USD-47.60%Mkt Cap: —P/E: —

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap—
Enterprise Value—
Revenue (TTM)1.62M USD
Gross Profit566.31K USD
Net Income (TTM)-8.23M USD
Revenue/Share0.13 USD
Last Price1.310 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B1.26
EPS (TTM)-0.51
EPS (Forward)—
52W Range
0.354423% of range4.500
52W High4.500 USD
52W Low0.3544 USD
Profitability
Gross Margin27.81%
Oper. Margin-203.57%
EBITDA Margin0.00%
Profit Margin-404.08%
ROE-123.21%
ROA-109.03%
Growth
Revenue Growth-29.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.13M USD
CapEx (TTM)5.32K USD
FCF Margin-87.04%
FCF Yield—
Net Debt-3.20M USD
Net Debt/EBITDA0.46
Balance Sheet
Debt/Equity0.04
Current Ratio4.21
Quick Ratio3.80
Book Value/Sh0.44 USD
Cash/Share0.28 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float5.28M
Insiders—
Institutions—
Technical
SMA 500.6524 (+100.8%)
SMA 2001.112 (+17.9%)
Beta1.93
S&P 52W Chg15.78%
Avg Vol (30d)6.44K
Avg Vol (10d)18.63K
Technical Indicators
RSI (14)51.4
MACD0.0639
MACD Signal-0.0283
MACD Hist.+0.0923
BB Upper2.061 USD
BB Middle1.064 USD
BB Lower0.0667 USD
BB Width187.47%
ATR (14)0.4490 USD
Vol Ratio (20d)1.60x